-
1
-
-
1842563009
-
Hb content-based transfusion policy successfully reduces the number of RBC units transfused
-
DOI 10.1111/j.1537-2995.2004.03225.x
-
Arslan, O., Toprak, S., Arat, M., Kayalak, Y. (2004) Hb content-based transfusion policy successfully reduces the number of RBC units transfused. Transfusion, 44, 485 488. (Pubitemid 38437582)
-
(2004)
Transfusion
, vol.44
, Issue.4
, pp. 485-488
-
-
Arslan, O.1
Toprak, S.2
Arat, M.3
Kayalak, Y.4
-
2
-
-
0034068021
-
Quality assurance by a commercial flow cytometry method of leucodepletion of whole blood donations: Initial application of universal testing and proposals for a batch-release sampling plan
-
DOI 10.1046/j.1365-3148.2000.00230.x
-
Barclay, G.R., Walker, B., Gibson, J., McColl, K., Turner, M.L. (2000) Quality assurance by a commercial flow cytometry method of leucodepletion of whole blood donations: initial application of universal testing and proposals for a batch-release sampling plan. Transfusion Medicine, 10, 37 48. (Pubitemid 30166236)
-
(2000)
Transfusion Medicine
, vol.10
, Issue.1
, pp. 37-48
-
-
Barclay, G.R.1
Walker, B.2
Gibson, J.3
McColl, K.4
Turner, M.L.5
-
3
-
-
0017367439
-
Dangers of accidental person to person transmission of Creutzfeldt Jakob disease by surgery
-
Bernoulli, C., Siegfried, J., Baumgartner, G., Regli, F., Rabinowicz, T., Gajdusek, D.C., Gibbs, C.J. (1977) Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet, 1, 478 479. (Pubitemid 8045134)
-
(1977)
Lancet
, vol.1
, Issue.8009
, pp. 478-479
-
-
Bernoulli, C.1
Siegfried, J.2
Baumgartner, G.3
-
4
-
-
0032757723
-
Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans
-
Brown, P., Cervenáková, L., McShane, L.M., Barber, P., Rubenstein, R., Drohan, W.N. (1999) Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion, 39, 1169 1178.
-
(1999)
Transfusion
, vol.39
, pp. 1169-1178
-
-
Brown, P.1
Cervenáková, L.2
McShane, L.M.3
Barber, P.4
Rubenstein, R.5
Drohan, W.N.6
-
5
-
-
3543092761
-
The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy
-
Brown, P., Rohwer, R.G., Dunstan, B.C., MacAuley, C., Gajdusek, D.C., Drohan, W.N. (1998) The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion, 38, 810 816. (Pubitemid 28421640)
-
(1998)
Transfusion
, vol.38
, Issue.9
, pp. 810-816
-
-
Brown, P.1
Rohwer, R.G.2
Dunstan, B.C.3
MacAuley, C.4
Gajdusek, D.C.5
Drohan, W.N.6
-
7
-
-
0027409810
-
Creutzfeldt-Jakob disease and blood transfusion
-
DOI 10.1016/0140-6736(93)90068-R
-
Esmonde, T.F., Will, R.G., Slattery, J.M., Knight, R., Harries-Jones, R., de Silva, R., Mathews, W.B. (1993) Creutzfeldt-Jakob disease and blood transfusion. Lancet, 341, 205 207. (Pubitemid 23048084)
-
(1993)
Lancet
, vol.341
, Issue.8839
, pp. 205-207
-
-
Esmonde, T.F.G.1
Will, R.G.2
Slattery, J.M.3
Knight, R.4
Harries-Jones, R.5
De Silva, R.6
Matthews, W.B.7
-
8
-
-
33845612714
-
Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins
-
DOI 10.1016/S0140-6736(06)69897-8, PII S0140673606698978
-
Gregori, L., Gurgel, P.V., Lathrop, J.T. et al 2006a) Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins. Lancet, 368, 2226 2230. (Pubitemid 44959015)
-
(2006)
Lancet
, vol.368
, Issue.9554
, pp. 2226-2230
-
-
Gregori, L.1
Gurgel, P.V.2
Lathrop, J.T.3
Edwardson, P.4
Lambert, B.C.5
Carbonell, R.G.6
Burton, S.J.7
Hammond, D.J.8
Rohwer, R.G.9
-
9
-
-
33746501354
-
Reduction of transmissible spongiform encephalopathy infectivity from human red blood cells with prion protein affinity ligands
-
DOI 10.1111/j.1537-2995.2006.00865.x
-
Gregori, L., Lambert, B.C., Gurgel, P.V. et al 2006b) Reduction of transmissible spongiform encephalopathy infectivity from human red blood cells with prion protein affinity ligands. Transfusion, 46, 1152 1161. (Pubitemid 44139489)
-
(2006)
Transfusion
, vol.46
, Issue.7
, pp. 1152-1161
-
-
Gregori, L.1
Lambert, B.C.2
Gurgel, P.V.3
Gheorghiu, L.4
Edwardson, P.5
Lathrop, J.T.6
MacAuley, C.7
Carbonell, R.G.8
Burton, S.J.9
Hammond, D.10
Rohwer, R.G.11
-
10
-
-
4043054277
-
Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood
-
DOI 10.1016/S0140-6736(04)16812-8, PII S0140673604168128
-
Gregori, L., McCombie, N., Palmer, D., Birch, P., Sowemino-Coker, S.O., Giulivi, A., Rohwer, R.G. (2004) Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encaphalopathies from blood. Lancet, 364, 529 531. (Pubitemid 39070414)
-
(2004)
Lancet
, vol.364
, Issue.9433
, pp. 529-531
-
-
Gregori, L.1
McCombie, N.2
Palmer, D.3
Birch, P.4
Sowemimo-Coker, S.O.5
Giulivi, A.6
Rohwer, R.G.7
-
12
-
-
0033573778
-
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples
-
DOI 10.1016/S0140-6736(98)12075-5
-
Hill, A.F., Butterworth, R.J., Joiner, S. et al 1999) Investigation of variant Creutzfeldt Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet, 353, 183 189. (Pubitemid 29088029)
-
(1999)
Lancet
, vol.353
, Issue.9148
, pp. 183-189
-
-
Hill, A.F.1
Butterworth, R.J.2
Joiner, S.3
Jackson, G.4
Rossor, M.N.5
Thomas, D.J.6
Frosh, A.7
Tolley, N.8
Bell, J.E.9
Spencer, M.10
King, A.11
Al-Sarraj, S.12
Ironside, J.W.13
Lantos, P.L.14
Collinge, J.15
-
13
-
-
0034675211
-
Transmission of BSE by blood transfusion in sheep
-
Houston, F., Foster, J.D., Chong, A., Hunter, N., Bostock, C.J. (2000) Transmission of BSE by blood transfusion in sheep. Lancet, 356, 999 1000.
-
(2000)
Lancet
, vol.356
, pp. 999-1000
-
-
Houston, F.1
Foster, J.D.2
Chong, A.3
Hunter, N.4
Bostock, C.J.5
-
14
-
-
58149378573
-
Prion diseases are efficiently transmitted by blood transfusion in sheep
-
Houston, F., McCutcheon, S., Goldmann, W. et al 2008) Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood, 112, 4739 4745.
-
(2008)
Blood
, vol.112
, pp. 4739-4745
-
-
Houston, F.1
McCutcheon, S.2
Goldmann, W.3
Al, E.4
-
15
-
-
0141609860
-
Variant Creutzfeldt-Jakob disease and its transmission by blood
-
Ironside, J.W., Head, M.W. (2003) Variant Creutzfeldt-Jakob disease and its transmission by blood. Journal of Thrombosis and Haemostasis, 1, 479 486.
-
(2003)
Journal of Thrombosis and Haemostasis
, vol.1
, pp. 479-486
-
-
Ironside, J.W.1
Head, M.W.2
-
16
-
-
0031444295
-
A crucial role for B cells in neuroinvasive scraple
-
DOI 10.1038/37789
-
Klein, M.A., Frigg, R., Flechsig, E. et al 1997) A crucial role for B cells in neuroinvasive scrapie. Nature, 390, 687 690. (Pubitemid 28016356)
-
(1997)
Nature
, vol.390
, Issue.6661
, pp. 687-690
-
-
Klein, M.A.1
Frigg, R.2
Flechsig, E.3
Raeber, A.J.4
Kalinke, U.5
Bluethmann, H.6
Bootz, F.7
Suter, M.8
Zinkernagel, R.M.9
Aguzzi, A.10
-
17
-
-
0002633963
-
Adenosine-5'-tri- phosphate. Determination with hexokinase and glucose-6-phosphate dehydrogenase
-
In. (eds. Bergmeyer, H.U.). Academic Press. New York.
-
Lamprecht, W., Trautschold, I. (1974) Adenosine-5'-tri- phosphate. Determination with hexokinase and glucose-6-phosphate dehydrogenase. In: Methods of Enzymatic Analysis (eds Bergmeyer, H.U.). 2102 2110. Academic Press, New York.
-
(1974)
Methods of Enzymatic Analysis
, pp. 2102-2110
-
-
Lamprecht, W.1
Trautschold, I.2
-
18
-
-
1142273431
-
Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion
-
DOI 10.1016/S0140-6736(04)15486-X
-
Llewelyn, C.A., Hewitt, P.E., Knight, R.S.G., Amar, K., Couesens, S., Mackenzie. J., Will, R.G. (2004) Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet, 363, 417 421. (Pubitemid 38210057)
-
(2004)
Lancet
, vol.363
, Issue.9407
, pp. 417-421
-
-
Llewelyn, C.A.1
Hewitt, P.E.2
Knight, R.S.G.3
Amar, K.4
Cousens, S.5
MacKenzie, J.6
Will, R.G.7
-
19
-
-
67651167824
-
-
National Creutzfeldt-Jakob Disease Surveillance Unit (NCJDSU). UK. 4 July. (Accessed 10/7/2008).
-
National Creutzfeldt-Jakob Disease Surveillance Unit (NCJDSU), UK http://www.cjd.ed.ac.uk/vcjdworld.htm 4 July (2008) (Accessed 10/7/2008).
-
(2008)
-
-
-
20
-
-
4043157677
-
Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient
-
DOI 10.1016/S0140-6736(04)16811-6, PII S0140673604168116
-
Peden, A.H., Head, M.W., Ritchie, D.L., Bell, J.E., Ironside, J.W. (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet, 364, 527 529. (Pubitemid 39070413)
-
(2004)
Lancet
, vol.364
, Issue.9433
, pp. 527-529
-
-
Peden, A.H.1
Head, M.W.2
Ritchie, D.L.3
Bell, P.J.E.4
Ironside, P.J.W.5
-
21
-
-
27844526948
-
In-vitro evaluation of the PALL Leukotrap affinity prion reduction filter as a secondary device following primary leucoreduction
-
DOI 10.1111/j.1423-0410.2005.00703.x
-
Saunders, C., Herbert, P., Rowe, G. et al 2005) In-vitro evaluation of the PALL Leukotrap Affinity Prion Reduction Filter as a secondary device following primary leucoreduction. Vox Sanguinis, 89, 220 228. (Pubitemid 41641102)
-
(2005)
Vox Sanguinis
, vol.89
, Issue.4
, pp. 220-228
-
-
Saunders, C.1
Herbert, P.2
Rowe, G.3
Hayward, M.4
Wilkins, K.5
Milligan, J.6
Stenning, M.7
Seacombe, A.8
Prowse, C.9
-
22
-
-
33646093707
-
Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates
-
Sowemimo-Coker, S.O., Pesci, S., Andrade, F., Kim, A., Kascsak, R.B., Kascsak, R.J., Meeker, C., Carp, R. (2006) Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates. Vox Sanguinis, 90, 265 275.
-
(2006)
Vox Sanguinis
, vol.90
, pp. 265-275
-
-
Sowemimo-Coker, S.O.1
Pesci, S.2
Andrade, F.3
Kim, A.4
Kascsak, R.B.5
Kascsak, R.J.6
Meeker, C.7
Carp, R.8
-
23
-
-
67651197958
-
-
United Kingdom Health Protection Agency (HPA). Variant CJD and blood donors and recipients (updated 9 April 2008).
-
United Kingdom Health Protection Agency (HPA) Variant CJD and blood donors and recipients (updated 9 April 2008). http://www.hpa.org.uk/infections/ topics-az/cjd/menu.htm.
-
-
-
-
24
-
-
0032751789
-
Risk of transmission of Creutzfeldt-Jakob disease by transfusion of blood, plasma, and plasma derivatives
-
DOI 10.1002/(SICI)1098-1101(1999)14:3<135::AID-JCA6>3.0.CO;2-S
-
Vamvakas, E.C. (1999) Risk of transmission of Creutzfeldt-Jakob disease by transfusion of blood, plasma, and plasma derivatives. Journal of Clinical Apheresis, 14, 135 143. (Pubitemid 29530449)
-
(1999)
Journal of Clinical Apheresis
, vol.14
, Issue.3
, pp. 135-143
-
-
Vamvakas, E.C.1
-
25
-
-
0034237683
-
Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions: Systematic review of case-control studies
-
Wilson, K., Code, C., Ricketts, M. (2000) Risk of acquiring Creutzfeldt-Jakob disease from blood transfusion: systematic review of case-control studies. British Medical Journal, 321, 17 19. (Pubitemid 30417018)
-
(2000)
British Medical Journal
, vol.321
, Issue.7252
, pp. 17-19
-
-
Wilson, K.1
Code, C.2
Ricketts, M.N.3
|